ArticleArab journal of urology2023

Can we offer additional BCG therapy for three-month BCG refractory high grade/T1, Tis bladder cancer patients?

Amr A Elsawy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.